Nitric oxide-donating
aspirin (
NO-ASA) is a promising agent for
cancer prevention. Although studied extensively, its molecular targets and mechanism of action are still unclear. S-nitrosylation of signaling
proteins is emerging as an important regulatory mechanism by NO. Here, we examined whether S-nitrosylation of the NF-κB, p53, and Wnt signaling
proteins by
NO-ASA might explain, in part, its mechanism of action in
colon cancer.
NO-ASA releases significant amounts of NO detected intracellularly in HCT116 and HT-29 colon cells. Using a modified
biotin switch assay we demonstrated that
NO-ASA S-nitrosylates the signaling
proteins p53, β-
catenin, and NF-κB, in
colon cancer cells in a time- and concentration-dependent manner.
NO-ASA suppresses NF-κB binding to its cognate
DNA oligonucleotide, which occurs without changes in the nuclear levels of the NF-κB subunits p65 and p50 and is reversed by
dithiothreitol that reduces -S-NO to -SH. In addition to S-nitrosylation, we documented both in vitro and in vivo widespread nitration of
tyrosine residues of cellular
proteins in response to
NO-ASA. Our results suggest that the increased intracellular NO levels following treatment with
NO-ASA modulate cell signaling by chemically modifying key
protein members of signaling cascades. We speculate that S-nitrosylation and
tyrosine nitration are responsible, at least in part, for the inhibitory growth effect of
NO-ASA on
cancer cell growth and that this may represent a general mechanism of action of NO-releasing agents.